ReviewJournal of clinical pathology2003
Salivary gland-like tumours of the breast: surgical and molecular pathology.
Review in Journal of clinical pathology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 68 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
68 citing papers in PubMed, 212 citations in OpenAlex.
- Artificial Intelligence for Diagnostic and Prognostic Support in Breast Cancer: A Literature Overview.Cancers · 2026Review
- Clinicopathologic features, treatment patterns and survival outcomes of acinic cell carcinoma of the breast: a national cancer database analysis.Breast cancer research and treatment · 2026Article
- Comparative Transcriptomics Suggests that Breast Secretory Epithelium Reuses Gene Repertoires Conserved Across Vertebrates Beyond Mammals.Genome biology and evolution · 2026Article
- Article
- Case Report: Pleomorphic adenoma of the breast: diagnostic pitfalls and a novel PLAG1::FTO fusion.Frontiers in oncology · 2026Article
- A clinicopathologic and survival analysis of mucoepidermoid carcinoma of the breast.Contemporary oncology (Poznan, Poland) · 2026Article
- Wnt/β-catenin activation by mutually exclusive FBXW11 and CTNNB1 hotspot mutations drives salivary basal cell adenoma.Nature communications · 2025Article
- A rare case of recurrent adenoid cystic carcinoma of the breast with weak hormone receptor positivity.Radiology case reports · 2025Article
- A Case of Pleomorphic Adenoma and Ductal Carcinoma In Situ in the Same Mammary Gland.Surgical case reports · 2025Article
- Challenging the extended phenotype: HRD-negative salivary gland carcinoma in aFrontiers in oncology · 2025Article
- Case Report: Mucoepidermoid carcinoma in rare locations: a report of two cases.Frontiers in oncology · 2025Article
- A case of high-grade adenosquamous carcinoma of the breast: case report and literature review.Frontiers in oncology · 2025Review
- Very rare tumour of the palatine tonsil: a molecular approach.BMJ case reports · 2024Article
- Breast acinic cell carcinoma with weak progesterone receptor expression: a case report and literature review.Frontiers in oncology · 2024Article
- Article
- Primary mucoepidermoid carcinoma of the breast arising in adenomyoepithelioma.BMJ case reports · 2022Article
- Pathogenesis of Triple-Negative Breast Cancer.Annual review of pathology · 2022Review
- PCP4/PEP19 and HER2 Are Novel Prognostic Markers in Mucoepidermoid Carcinoma of the Salivary Gland.Cancers · 2021Article
- Molecular Pathology of Breast Tumors: Diagnostic and Actionable Genetic Alterations.Surgical pathology clinics · 2021Review
- Risk of breast cancer in women after a salivary gland carcinoma or pleomorphic adenoma in the Netherlands.Cancer medicine · 2021Article
8 more citing papers are in PubMed but not listed here.
Corrections and comments
- Erratum issued
Authors and funding
4 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast glands and salivary glands are tubulo-acinar exocrine glands that can manifest as tumours with similar morphological features, but that differ in incidence and clinical behaviour depending on whether they are primary in breast or salivary glands. Salivary gland-like tumours of the breast are of two types: tumours with myoepithelial differentiation and those devoid of myoepithelial differentiation. The first and more numerous group comprises a spectrum of lesions ranging from "bona fide" benign (such as benign myoepithelioma and pleomorphic adenoma), to low grade malignant (such as adenoid cystic carcinoma, low grade adenosquamous carcinoma, and adenomyoepithelioma), to high grade malignant lesions (malignant myoepithelioma). The second group comprises lesions that have only recently been recognised, such as acinic cell carcinoma, oncocytic carcinoma of the breast, and the rare mucoepidermoid carcinoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.